p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer

Although postoperative adjuvant therapy for non‐small cell lung cancer (NSCLC) had not been reported to be effective, it has been reported recently that oral administration of tegafur (1‐[2‐tetrahydrofuryl]‐5‐fluorouracil, FT) may improve the postoperative prognosis. In the present paper, to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Fumihiro, Yanagihara, Kazuhiro, Ohtake, Yohsuke, Miyahara, Ryou, Kawano, Youzou, Fukuse, Tatsuo, Hitomi, Shigeki, Wada, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1999
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926087/
https://www.ncbi.nlm.nih.gov/pubmed/10363582
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00766.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926087/
https://www.ncbi.nlm.nih.gov/pubmed/10363582
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00766.x

Ejemplares similares